Water Quality in MONTGOMERY, NY (12549)
EPA violation data for public water systems serving ZIP code 12549.
715
Total Violations
17
Health-Based
698
Monitoring / Reporting
674
Resolved
What does this mean?
674 of 715 violations have been resolved. 17 are health-based violations, meaning contaminant levels exceeded federal safety limits. The remaining 698 are monitoring or reporting violations (missed testing deadlines or late paperwork — not necessarily a water quality issue). Not all violations mean your water is unsafe. The EPA requires reporting even for minor administrative issues.
Violations Detail (715 total)
| Contaminant | Category | MCL Limit | Measured | Date | Status | Health Effects |
|---|---|---|---|---|---|---|
| Public Notice | Monitoring | N/A | N/A | Aug 30, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 30, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 30, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 30, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 16, 2025 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Active | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 17, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | May 17, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | May 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 10, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | May 10, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | May 10, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | May 10, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | May 10, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | May 10, 2025 | Active | N/A |
| Benzene | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 1, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 1, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 1, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 1, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 1, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 1, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 1, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 1, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 8, 2024 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 17, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 17, 2024 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Benzene | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Public Notice | Monitoring | N/A | N/A | Apr 27, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 27, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 27, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 27, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 27, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 27, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 27, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 27, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 27, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 27, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 27, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 27, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 27, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 27, 2024 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 30, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 2, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 2, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 2, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 24, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 24, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 24, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 24, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 24, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 24, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 24, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 24, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 24, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 24, 2024 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Lead and Copper Rule | Health-Based | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Lead and Copper Rule | Health-Based | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Lead and Copper Rule | Health-Based | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 25, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 25, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 25, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 25, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 17, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 17, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Lead and Copper Rule | Health-Based | N/A | N/A | Sep 16, 2023 | Resolved | N/A |
| Lead and Copper Rule | Health-Based | N/A | N/A | Sep 16, 2023 | Resolved | N/A |
| Lead and Copper Rule | Health-Based | N/A | N/A | Sep 16, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 15, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 15, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 13, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 13, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 13, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 7, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 7, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 7, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 7, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 7, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 7, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 30, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 30, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 30, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Benzene | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Health-Based | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Health-Based | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Total Polychlorinated Biphenyls (PCB) | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Total Polychlorinated Biphenyls (PCB) | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Total Polychlorinated Biphenyls (PCB) | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Total Polychlorinated Biphenyls (PCB) | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| LASSO | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| OXAMYL | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| OXAMYL | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| OXAMYL | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| OXAMYL | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Aldicarb sulfoxide | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Aldicarb sulfoxide | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Aldicarb sulfoxide | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Aldicarb sulfoxide | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Aldicarb sulfone | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Aldicarb sulfone | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Aldicarb sulfone | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Aldicarb sulfone | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Carbofuran | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Carbofuran | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Carbofuran | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Carbofuran | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Aldicarb | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Aldicarb | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Aldicarb | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Aldicarb | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| ETHYLENE DIBROMIDE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| ETHYLENE DIBROMIDE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| ETHYLENE DIBROMIDE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| ETHYLENE DIBROMIDE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Picloram | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Dalapon | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Picloram | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Health-Based | N/A | N/A | Dec 31, 2022 | Active | N/A |
| Atrazine | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Cardiovascular system or reproductive problems |
| Atrazine | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Cardiovascular system or reproductive problems |
| Picloram | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Atrazine | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Cardiovascular system or reproductive problems |
| Atrazine | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Cardiovascular system or reproductive problems |
| Picloram | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Health-Based | N/A | N/A | Dec 31, 2022 | Active | N/A |
| Dalapon | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Dalapon | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Dalapon | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Health-Based | N/A | N/A | Dec 30, 2022 | Active | N/A |
| Lead and Copper Rule | Health-Based | N/A | N/A | Dec 30, 2022 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2022 | Resolved | N/A |
| Benzene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| ETHYLENE DIBROMIDE | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Atrazine | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Cardiovascular system or reproductive problems |
| Atrazine | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Cardiovascular system or reproductive problems |
| Atrazine | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Cardiovascular system or reproductive problems |
| Methoxychlor | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| ETHYLENE DIBROMIDE | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Total Polychlorinated Biphenyls (PCB) | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Total Polychlorinated Biphenyls (PCB) | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| OXAMYL | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| OXAMYL | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| OXAMYL | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Dalapon | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| ETHYLENE DIBROMIDE | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Dalapon | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Dalapon | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Total Polychlorinated Biphenyls (PCB) | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Aldicarb | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Aldicarb | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Aldicarb | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Picloram | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Picloram | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Picloram | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Aldicarb sulfoxide | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Aldicarb sulfoxide | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Aldicarb sulfoxide | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Aldicarb sulfone | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Aldicarb sulfone | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Aldicarb sulfone | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Carbofuran | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Carbofuran | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Carbofuran | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Lead and Copper Rule | Health-Based | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Dalapon | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| OXAMYL | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Dalapon | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Dalapon | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| OXAMYL | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| OXAMYL | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Aldicarb sulfoxide | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| ETHYLENE DIBROMIDE | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| ETHYLENE DIBROMIDE | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| ETHYLENE DIBROMIDE | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Aldicarb sulfoxide | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Aldicarb sulfoxide | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Aldicarb sulfone | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Aldicarb sulfone | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Aldicarb sulfone | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Carbofuran | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Carbofuran | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Carbofuran | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Aldicarb | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Aldicarb | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Aldicarb | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Atrazine | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Cardiovascular system or reproductive problems |
| Atrazine | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Cardiovascular system or reproductive problems |
| Atrazine | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Cardiovascular system or reproductive problems |
| Benzene | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Heptachlor epoxide | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Total Polychlorinated Biphenyls (PCB) | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Picloram | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Picloram | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Picloram | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Total Polychlorinated Biphenyls (PCB) | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Total Polychlorinated Biphenyls (PCB) | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| OXAMYL | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Picloram | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Picloram | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Picloram | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| ETHYLENE DIBROMIDE | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| ETHYLENE DIBROMIDE | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| ETHYLENE DIBROMIDE | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| OXAMYL | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| OXAMYL | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Dalapon | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Aldicarb | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Aldicarb | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Aldicarb | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Dalapon | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Dalapon | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Aldicarb sulfoxide | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Aldicarb sulfoxide | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Aldicarb sulfoxide | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Total Polychlorinated Biphenyls (PCB) | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Total Polychlorinated Biphenyls (PCB) | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Total Polychlorinated Biphenyls (PCB) | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Aldicarb sulfone | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Aldicarb sulfone | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Aldicarb sulfone | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Atrazine | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Cardiovascular system or reproductive problems |
| Atrazine | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Cardiovascular system or reproductive problems |
| Atrazine | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Cardiovascular system or reproductive problems |
| BHC-GAMMA | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Carbofuran | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Benzene | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Chlordane | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Benzene | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Carbofuran | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Carbofuran | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2022 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Chromium | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Allergic dermatitis |
| Chromium | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Allergic dermatitis |
| Chromium | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Allergic dermatitis |
| CYANIDE | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Nerve damage or thyroid problems |
| CYANIDE | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Nerve damage or thyroid problems |
| CYANIDE | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Nerve damage or thyroid problems |
| Selenium | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Selenium | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Selenium | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Nickel | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Nickel | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Nickel | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Thallium, Total | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Thallium, Total | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Thallium, Total | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Cadmium | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Kidney damage |
| Cadmium | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Kidney damage |
| Cadmium | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Kidney damage |
| Fluoride | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Antimony, Total | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Antimony, Total | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Barium | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Increase in blood pressure |
| Barium | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Increase in blood pressure |
| Beryllium, Total | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Beryllium, Total | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Beryllium, Total | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Mercury | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Kidney damage |
| Mercury | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Kidney damage |
| Mercury | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Kidney damage |
| Antimony, Total | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Barium | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Increase in blood pressure |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Lead and Copper Rule | Health-Based | N/A | N/A | Sep 13, 2021 | Resolved | N/A |
| Lead and Copper Rule | Health-Based | N/A | N/A | Sep 13, 2021 | Resolved | N/A |
| Lead and Copper Rule | Health-Based | N/A | N/A | Sep 13, 2021 | Resolved | N/A |
| Lead and Copper Rule | Health-Based | N/A | N/A | Sep 13, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
Lead & Copper Levels
Violation Timeline
2025(40)
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
76
Public Notice
75
Revised Total Coliform Rule
3A
Consumer Confidence Rule
71
Consumer Confidence Rule
71
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
76
Public Notice
76
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Benzene
03
Benzene
03
Revised Total Coliform Rule
3B
Revised Total Coliform Rule
3B
Revised Total Coliform Rule
3B
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
2024(53)
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Revised Total Coliform Rule
3B
Revised Total Coliform Rule
3B
Total Haloacetic Acids (HAA5)
27
Total Haloacetic Acids (HAA5)
27
Total Haloacetic Acids (HAA5)
27
Total Haloacetic Acids (HAA5)
27
TTHM
27
TTHM
27
TTHM
27
TTHM
27
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Benzene
03
Benzene
03
Benzene
03
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
TTHM
27
TTHM
27
Total Haloacetic Acids (HAA5)
27
Total Haloacetic Acids (HAA5)
27
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
2023(72)
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Benzene
03
Benzene
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Benzene
03
Revised Total Coliform Rule
3A
Benzene
03
Benzene
03
Benzene
03
Total Haloacetic Acids (HAA5)
27
Total Haloacetic Acids (HAA5)
27
TTHM
27
TTHM
27
Lead and Copper Rule
57
Lead and Copper Rule
57
Lead and Copper Rule
57
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
76
Public Notice
76
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Lead and Copper Rule
65
Lead and Copper Rule
65
Lead and Copper Rule
65
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Consumer Confidence Rule
71
Consumer Confidence Rule
71
Consumer Confidence Rule
71
Consumer Confidence Rule
71
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Benzene
03
Benzene
03
Benzene
03
2022(483)
Lead and Copper Rule
52
Lead and Copper Rule
52
Lead and Copper Rule
52
Lead and Copper Rule
52
Lead and Copper Rule
57
Lead and Copper Rule
57
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Benzene
03
Benzene
03
Benzene
03
Benzene
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Benzene
03
Benzene
03
Benzene
03
Benzene
03
Benzene
03
Benzene
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Total Haloacetic Acids (HAA5)
27
Total Haloacetic Acids (HAA5)
27
Total Haloacetic Acids (HAA5)
27
Total Haloacetic Acids (HAA5)
27
Total Haloacetic Acids (HAA5)
27
Total Haloacetic Acids (HAA5)
27
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
TTHM
27
TTHM
27
TTHM
27
TTHM
27
TTHM
27
TTHM
27
Lead and Copper Rule
52
Lead and Copper Rule
52
Simazine
03
Simazine
03
Simazine
03
HEXACHLOROBENZENE
03
HEXACHLOROBENZENE
03
HEXACHLOROBENZENE
03
HEXACHLOROBENZENE
03
Dinoseb
03
Dinoseb
03
Dinoseb
03
Dinoseb
03
Simazine
03
Benzo(a)pyrene
03
Benzo(a)pyrene
03
Benzo(a)pyrene
03
Pentachlorophenol
03
Pentachlorophenol
03
Pentachlorophenol
03
Pentachlorophenol
03
Total Polychlorinated Biphenyls (PCB)
03
Total Polychlorinated Biphenyls (PCB)
03
Chlordane
03
Chlordane
03
Chlordane
03
Chlordane
03
Heptachlor
03
Heptachlor
03
Heptachlor
03
Heptachlor
03
Di(2-ethylhexyl) phthalate
03
Di(2-ethylhexyl) phthalate
03
Di(2-ethylhexyl) phthalate
03
Di(2-ethylhexyl) phthalate
03
Total Polychlorinated Biphenyls (PCB)
03
Total Polychlorinated Biphenyls (PCB)
03
Lead and Copper Rule
52
Benzene
03
Benzene
03
Benzene
03
LASSO
03
LASSO
03
LASSO
03
LASSO
03
Benzene
03
Benzo(a)pyrene
03
Endrin
03
Endrin
03
Endrin
03
Endrin
03
BHC-GAMMA
03
BHC-GAMMA
03
BHC-GAMMA
03
BHC-GAMMA
03
Methoxychlor
03
Methoxychlor
03
Methoxychlor
03
Methoxychlor
03
Toxaphene
03
Toxaphene
03
Toxaphene
03
Toxaphene
03
Di(2-ethylhexyl) adipate
03
Di(2-ethylhexyl) adipate
03
Di(2-ethylhexyl) adipate
03
Di(2-ethylhexyl) adipate
03
OXAMYL
03
OXAMYL
03
OXAMYL
03
OXAMYL
03
Hexachlorocyclopentadiene
03
Hexachlorocyclopentadiene
03
Hexachlorocyclopentadiene
03
Hexachlorocyclopentadiene
03
Aldicarb sulfoxide
03
Aldicarb sulfoxide
03
Aldicarb sulfoxide
03
Aldicarb sulfoxide
03
Aldicarb sulfone
03
Aldicarb sulfone
03
Aldicarb sulfone
03
Aldicarb sulfone
03
Carbofuran
03
Carbofuran
03
Carbofuran
03
Carbofuran
03
Aldicarb
03
Aldicarb
03
Aldicarb
03
Aldicarb
03
Heptachlor epoxide
03
Heptachlor epoxide
03
Heptachlor epoxide
03
Heptachlor epoxide
03
2,4-D
03
2,4-D
03
2,4-D
03
2,4-D
03
2,4,5-TP
03
2,4,5-TP
03
2,4,5-TP
03
2,4,5-TP
03
ETHYLENE DIBROMIDE
03
ETHYLENE DIBROMIDE
03
ETHYLENE DIBROMIDE
03
ETHYLENE DIBROMIDE
03
Picloram
03
Dalapon
03
Picloram
03
Lead and Copper Rule
57
Atrazine
03
Atrazine
03
Picloram
03
Atrazine
03
Atrazine
03
Picloram
03
Lead and Copper Rule
57
Dalapon
03
Dalapon
03
Dalapon
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Lead and Copper Rule
57
Lead and Copper Rule
57
Revised Total Coliform Rule
3B
Revised Total Coliform Rule
3B
Revised Total Coliform Rule
3B
Revised Total Coliform Rule
3B
Benzene
03
Benzene
03
Benzene
03
ETHYLENE DIBROMIDE
03
2,4,5-TP
03
Atrazine
03
Atrazine
03
Atrazine
03
Methoxychlor
03
Methoxychlor
03
Methoxychlor
03
Di(2-ethylhexyl) phthalate
03
Di(2-ethylhexyl) phthalate
03
ETHYLENE DIBROMIDE
03
Total Polychlorinated Biphenyls (PCB)
03
Total Polychlorinated Biphenyls (PCB)
03
OXAMYL
03
OXAMYL
03
OXAMYL
03
BHC-GAMMA
03
BHC-GAMMA
03
BHC-GAMMA
03
Chlordane
03
Chlordane
03
Chlordane
03
Dalapon
03
ETHYLENE DIBROMIDE
03
Dalapon
03
Dalapon
03
Endrin
03
Endrin
03
Endrin
03
Heptachlor
03
Heptachlor
03
Heptachlor
03
Total Polychlorinated Biphenyls (PCB)
03
Aldicarb
03
Pentachlorophenol
03
Pentachlorophenol
03
Aldicarb
03
Aldicarb
03
Picloram
03
Picloram
03
Dinoseb
03
Dinoseb
03
Dinoseb
03
Picloram
03
Simazine
03
Simazine
03
Simazine
03
Pentachlorophenol
03
Di(2-ethylhexyl) adipate
03
Di(2-ethylhexyl) adipate
03
Di(2-ethylhexyl) adipate
03
Hexachlorocyclopentadiene
03
Hexachlorocyclopentadiene
03
Hexachlorocyclopentadiene
03
Aldicarb sulfoxide
03
Aldicarb sulfoxide
03
Aldicarb sulfoxide
03
Aldicarb sulfone
03
Aldicarb sulfone
03
Aldicarb sulfone
03
Carbofuran
03
Carbofuran
03
Carbofuran
03
LASSO
03
LASSO
03
LASSO
03
Heptachlor epoxide
03
Heptachlor epoxide
03
Heptachlor epoxide
03
HEXACHLOROBENZENE
03
HEXACHLOROBENZENE
03
HEXACHLOROBENZENE
03
2,4,5-TP
03
2,4,5-TP
03
Di(2-ethylhexyl) phthalate
03
Toxaphene
03
2,4-D
03
Toxaphene
03
Benzo(a)pyrene
03
Benzo(a)pyrene
03
Benzo(a)pyrene
03
2,4-D
03
2,4-D
03
Toxaphene
03
Lead and Copper Rule
65
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Endrin
03
Endrin
03
Endrin
03
Toxaphene
03
Toxaphene
03
Toxaphene
03
Dalapon
03
OXAMYL
03
Di(2-ethylhexyl) phthalate
03
Di(2-ethylhexyl) phthalate
03
Di(2-ethylhexyl) phthalate
03
Simazine
03
Simazine
03
Simazine
03
Dalapon
03
Dalapon
03
OXAMYL
03
OXAMYL
03
Hexachlorocyclopentadiene
03
Hexachlorocyclopentadiene
03
Hexachlorocyclopentadiene
03
Aldicarb sulfoxide
03
ETHYLENE DIBROMIDE
03
ETHYLENE DIBROMIDE
03
ETHYLENE DIBROMIDE
03
Aldicarb sulfoxide
03
Aldicarb sulfoxide
03
Aldicarb sulfone
03
Aldicarb sulfone
03
Di(2-ethylhexyl) adipate
03
Di(2-ethylhexyl) adipate
03
Di(2-ethylhexyl) adipate
03
Aldicarb sulfone
03
Carbofuran
03
Carbofuran
03
Carbofuran
03
Aldicarb
03
Aldicarb
03
Methoxychlor
03
Methoxychlor
03
Methoxychlor
03
Aldicarb
03
Dinoseb
03
Heptachlor
03
Heptachlor
03
Heptachlor
03
Chlordane
03
Chlordane
03
Chlordane
03
Dinoseb
03
Dinoseb
03
Heptachlor epoxide
03
Atrazine
03
Atrazine
03
Atrazine
03
Benzene
03
Benzene
03
Benzene
03
Heptachlor epoxide
03
Heptachlor epoxide
03
2,4-D
03
2,4-D
03
2,4-D
03
2,4,5-TP
03
2,4,5-TP
03
2,4,5-TP
03
HEXACHLOROBENZENE
03
HEXACHLOROBENZENE
03
HEXACHLOROBENZENE
03
Benzo(a)pyrene
03
Benzo(a)pyrene
03
Benzo(a)pyrene
03
Pentachlorophenol
03
Pentachlorophenol
03
Pentachlorophenol
03
Total Polychlorinated Biphenyls (PCB)
03
BHC-GAMMA
03
Picloram
03
Picloram
03
Picloram
03
Total Polychlorinated Biphenyls (PCB)
03
Total Polychlorinated Biphenyls (PCB)
03
LASSO
03
LASSO
03
LASSO
03
BHC-GAMMA
03
BHC-GAMMA
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
OXAMYL
03
Methoxychlor
03
Simazine
03
Simazine
03
Simazine
03
Picloram
03
Picloram
03
Picloram
03
Dinoseb
03
Dinoseb
03
Dinoseb
03
Heptachlor
03
Heptachlor
03
Heptachlor
03
Heptachlor epoxide
03
Heptachlor epoxide
03
Heptachlor epoxide
03
2,4-D
03
2,4-D
03
2,4-D
03
HEXACHLOROBENZENE
03
HEXACHLOROBENZENE
03
HEXACHLOROBENZENE
03
Pentachlorophenol
03
Pentachlorophenol
03
Pentachlorophenol
03
ETHYLENE DIBROMIDE
03
ETHYLENE DIBROMIDE
03
ETHYLENE DIBROMIDE
03
OXAMYL
03
OXAMYL
03
Hexachlorocyclopentadiene
03
Hexachlorocyclopentadiene
03
Hexachlorocyclopentadiene
03
2,4,5-TP
03
Toxaphene
03
Toxaphene
03
Toxaphene
03
Dalapon
03
Di(2-ethylhexyl) phthalate
03
2,4,5-TP
03
2,4,5-TP
03
Aldicarb
03
Aldicarb
03
Aldicarb
03
Dalapon
03
Dalapon
03
Di(2-ethylhexyl) phthalate
03
Aldicarb sulfoxide
03
Aldicarb sulfoxide
03
Aldicarb sulfoxide
03
Di(2-ethylhexyl) phthalate
03
Total Polychlorinated Biphenyls (PCB)
03
Total Polychlorinated Biphenyls (PCB)
03
Total Polychlorinated Biphenyls (PCB)
03
Endrin
03
Aldicarb sulfone
03
Aldicarb sulfone
03
Aldicarb sulfone
03
Benzo(a)pyrene
03
Benzo(a)pyrene
03
Benzo(a)pyrene
03
Atrazine
03
Atrazine
03
Atrazine
03
BHC-GAMMA
03
BHC-GAMMA
03
BHC-GAMMA
03
Methoxychlor
03
Methoxychlor
03
Endrin
03
Endrin
03
Carbofuran
03
LASSO
03
LASSO
03
Benzene
03
Chlordane
03
Chlordane
03
Chlordane
03
Benzene
03
Benzene
03
Di(2-ethylhexyl) adipate
03
Carbofuran
03
Carbofuran
03
Di(2-ethylhexyl) adipate
03
Di(2-ethylhexyl) adipate
03
LASSO
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
2021(67)
Nitrate
03
Nitrate
03
Nitrate
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Chromium
03
Chromium
03
Chromium
03
CYANIDE
03
CYANIDE
03
CYANIDE
03
Selenium
03
Selenium
03
Selenium
03
Nickel
03
Nickel
03
Nickel
03
Arsenic
03
Thallium, Total
03
Thallium, Total
03
Thallium, Total
03
Arsenic
03
Arsenic
03
Cadmium
03
Cadmium
03
Cadmium
03
Fluoride
03
Fluoride
03
Fluoride
03
Antimony, Total
03
Antimony, Total
03
Barium
03
Barium
03
Beryllium, Total
03
Beryllium, Total
03
Beryllium, Total
03
Mercury
03
Mercury
03
Mercury
03
Antimony, Total
03
Barium
03
Nitrate
03
Benzene
03
Benzene
03
Benzene
03
Benzene
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Lead and Copper Rule
65
Lead and Copper Rule
65
Lead and Copper Rule
65
Lead and Copper Rule
65
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
How Does This Compare?
MONTGOMERY (12549) has 715 recorded violations, including 17 health-based. 41 remain unresolved. Consider testing your tap water independently for added peace of mind.
Recommended Water Filters
Based on the contaminants detected in your area, these filter types may help improve your water quality.
Reverse Osmosis System
Highly effective at removing heavy metals, dissolved solids, and a wide range of contaminants. Recommended for homes with lead or arsenic concerns.
Targets:Lead, Copper, Arsenic, Mercury, Cadmium
Look for:NSF/ANSI 58 certified
Activated Carbon Filter
Excellent for removing chlorine, chloramine, and disinfection byproducts like THMs and HAAs. Available as pitcher filters, countertop, or under-sink units.
Targets:THMs, HAAs, Chlorine, Chloramine, Taste & Odor
Look for:NSF/ANSI 42 & 53 certified
UV Water Purifier
Uses ultraviolet light to neutralize bacteria, viruses, and parasites without chemicals. Ideal for homes with microbial contamination concerns.
Targets:E. coli, Coliform, Giardia, Cryptosporidium
Look for:NSF/ANSI 55 (Class A) certified
Always look for filters certified by NSF International for the specific contaminants you want to remove.